West Pharmaceutical Services, Inc. (WST) has a MoatMap StockRank of 83/100 based on Quality (75/100), Value (18/100), and Momentum (73/100) factor scores. The current signal is STRONG BUY. West Pharmaceutical is the undisputed global leader in packaging components and delivery systems for injectable drugs (vials, stoppers, syringes). As GLP-1s and complex biologics scale exponentially, WST acts as a critical gatekeeper with an un-copyable regulatory moat (FDA master files). It shares scale economics with customers and possesses immense pricing power, making it a classic Terry Smith quality compounder riding a secular healthcare wave.
West Pharmaceutical Services is a global leader in designing and manufacturing high-quality containment and delivery systems for injectable drugs and other healthcare products, including stoppers, seals, and syringe components. The company's competitive moat is built upon its critical position as a trusted partner to pharmaceutical companies, extensive regulatory expertise, and proprietary technologies, which create high switching costs for drug packaging. West is a niche market leader, integral to the biopharmaceutical supply chain.
| Price | $312.17 |
| Market Cap | $22.7B |
| P/E (TTM) | 42.21 |
| P/E (Forward) | 33.10 |
| Price/Book | 7.50 |
| Return on Equity | 19.1% |
| Return on Invested Capital | 16.6% |
| Debt/Equity | 10.73 |
| Gross Margin | 36.3% |
| Operating Margin | 21.7% |
| Revenue Growth | 21.0% |
| Dividend Yield | 0.3% |
| Free Cash Flow | $276M |
West Pharmaceutical Services, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).